المؤلفون: Choueiri, T.K., Larkin, J., Pal, S., Motzer, R.J., Rini, B.I., Venugopal, B., Alekseev, B., Miyake, H., Gravis, G., Bilen, M.A., Hariharan, S., Chudnovsky, A., Ching, K.A., Mu, X.J., Mariani, M., Robbins, P.B., Huang, B., di Pietro, A., Albiges, L.

المساهمون: Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), Royal Marsden NHS Foundation Trust, City of Hope Comprehensive Cancer Center [Duarte], Memorial Sloane Kettering Cancer Center [New York], Vanderbilt University Medical Center [Nashville], Vanderbilt University [Nashville], University of Glasgow, P. Hertsen Moscow Oncology Research Institute, National Medical Research Radiological Centre, Hamamatsu University School of Medicine, Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Emory University [Atlanta, GA], Pfizer, Inc [Pearl River, New-York], Pfizer Global Research and Development [Cambridge, MA, USA], Pfizer Worldwide Research and Development [Groton, CT, USA], Institut Gustave Roussy (IGR), Département de médecine oncologique [Gustave Roussy]

المصدر: ESMO Open
ESMO Open, 2021, 6 (4), pp.100177. ⟨10.1016/j.esmoop.2021.100177⟩

مصطلحات موضوعية: Cancer Research, Axitinib, Oncology, Antineoplastic Combined Chemotherapy Protocols, Sunitinib, Humans, [SDV.CAN]Life Sciences [q-bio]/Cancer, Erratum, Antibodies, Monoclonal, Humanized, Carcinoma, Renal Cell, Kidney Neoplasms, ComputingMilieux_MISCELLANEOUS

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa995c446545c858053d19078b0df61bTest
https://hal-amu.archives-ouvertes.fr/hal-03623494Test

المؤلفون: Choueiri, T.K., Larkin, J., Pal, S., Motzer, R.J., Rini, B.I., Venugopal, B., Alekseev, B., Miyake, H., Gravis, G., Bilen, M.A., Hariharan, S., Chudnovsky, A., Ching, K.A., Mu, X.J., Mariani, M., Robbins, P.B., Huang, B., Di Pietro, A., Albiges, L.

المساهمون: Brigham & Women’s Hospital Boston (BWH), Harvard Medical School Boston (HMS), Royal Marsden NHS Foundation Trust, City of Hope Comprehensive Cancer Center Duarte, Memorial Sloane Kettering Cancer Center New York, Vanderbilt University Medical Center Nashville, Vanderbilt University Nashville, University of Glasgow, P. Hertsen Moscow Oncology Research Institute, National Medical Research Radiological Centre, Hamamatsu University School of Medicine, Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes (IPC), Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Emory University Atlanta, GA

المصدر: ISSN: 2059-7029 ; ESMO Open ; https://amu.hal.science/hal-03623572Test ; ESMO Open, 2021, 6 (3), pp.100101. ⟨10.1016/j.esmoop.2021.100101⟩.

مصطلحات موضوعية: JAVELIN Renal 101, avelumab, axitinib, renal cell carcinoma, sarcomatoid, [SDV.CAN]Life Sciences [q-bio]/Cancer

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33901870; hal-03623572; https://amu.hal.science/hal-03623572Test; PUBMED: 33901870; PUBMEDCENTRAL: PMC8099757

الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100101Test
https://amu.hal.science/hal-03623572Test